Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC)

CUSIP: G6717R104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / COMMON-STOCK
Shares outstanding
19,807,471
Total 13F shares
14,996,124
Share change
+6,006,088
Total reported value
$153,193,850
Price per share
$10.23
Number of holders
39
Value change
+$61,471,490
Number of buys
26
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G6717R104?
CUSIP G6717R104 identifies OACC - Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) as of Q1 2025

As of 31 Mar 2025, Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,996,124 shares. The largest 10 holders included AQR Arbitrage LLC, Driehaus Capital Management LLC, D. E. Shaw & Co., Inc., Boussard & Gavaudan Investment Management LLP, Decagon Asset Management LLP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Linden Advisors LP, GOLDMAN SACHS GROUP INC, LMR Partners LLP, and Harraden Circle Investments, LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.